Compare · KODK vs TMO
KODK vs TMO
Side-by-side comparison of Eastman Kodak Company Common New (KODK) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- KODK operates in Consumer Discretionary, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $174.52B, about 191.9x KODK ($909.6M).
- Over the past year, KODK is up 58.7% and TMO is up 14.9% - KODK leads by 43.8 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 10 for KODK).
- TMO has more recent analyst coverage (25 ratings vs 0 for KODK).
- Company
- Eastman Kodak Company Common New
- Thermo Fisher Scientific Inc
- Price
- $9.31+2.87%
- $469.56-0.67%
- Market cap
- $909.6M
- $174.52B
- 1M return
- -34.03%
- -1.03%
- 1Y return
- +58.69%
- +14.92%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 10
- 17
- Recent ratings
- 0
- 25
Eastman Kodak Company Common New
Eastman Kodak Company provides hardware, software, consumables, and services to customers in the commercial print, packaging, publishing, manufacturing, entertainment and commercial films, and consumer products markets worldwide. The company operates in four segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment offers digital offset plate and computer-to-plate imaging solutions to commercial industries, including commercial print, direct mail, book publishing, newspapers and magazines, and packaging. The Digital Printing segment offers electrophotographic printing solutions, such as DIGIMASTER and NEXFINITY printers; prosper products, including the PROSPER press systems and PROSPER components; versamark products; and Software comprising PRINERGY workflow production software. The Advanced Materials and Chemicals segment engages in industrial film and chemicals, motion picture, and advanced materials and functional printing businesses; and kodak services for business. This segment also comprises the Kodak Research Laboratories, which conducts research, develops new product or new business opportunities, and files patent applications for its inventions and innovations, as well as manages licensing of its intellectual property to third parties. The Brand segment engages in the licensing of Kodak brand to third parties. Additionally, it engages in the operation of Eastman Business Park, a technology center and industrial complex. The company sells its products and services through direct sales, third party resellers, and distributors. Eastman Kodak Company was founded in 1880 and is headquartered in Rochester, New York.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest KODK
- SEC Form SD filed by Eastman Kodak Company Common New
- Eastman Kodak Company Common New filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 4 filed by Director Katz Philippe D
- Director Bovenzi David converted options into 16,393 shares, increasing direct ownership by 46% to 52,142 units (SEC Form 4)
- Director Sileck Michael converted options into 16,393 shares, increasing direct ownership by 13% to 144,254 units (SEC Form 4)
- SEC Form 4 filed by Director Lynch Kathleen B.
- SEC Form 4 filed by Director New Jason Griffin
- CAO and Corp. Controller Michaels Richard T converted options into 10,000 shares and covered exercise/tax liability with 3,648 shares, increasing direct ownership by 27% to 30,182 units (SEC Form 4) (withholding obligation)
- CFO and Senior Vice President Bullwinkle David E converted options into 66,668 shares and covered exercise/tax liability with 24,034 shares, increasing direct ownership by 47% to 133,441 units (SEC Form 4) to satisfy tax liability
- General Counsel, Sec., SVP Byrd Roger W. converted options into 33,334 shares and covered exercise/tax liability with 8,118 shares, increasing direct ownership by 26% to 121,380 units (SEC Form 4) to satisfy tax liability
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)